Automated Sample Collection Error Detection in Clinical Assays

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current blood analysis systems fail to accurately distinguish and alert users to incorrect sample collection methods, particularly due to the use of inappropriate anticoagulants, leading to potentially erroneous test results that can impact patient health.

Innovation Solution

An algorithmic method within the analysis system that identifies the presence of incorrect anticoagulants by analyzing the concentration of specific ions and analytes, flagging affected tests and providing alerts to ensure accurate sample collection, using sensors like ion-selective electrodes to determine divalent and monovalent cations and other analytes, and setting threshold values to report inappropriate samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If users manually select collection tubes based on color-coded stoppers, then sample collection can be performed, but errors in tube selection occur due to user distraction and workload

Engineering Contradiction:
Improvesample collection processVSAvoidtube selection accuracy
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The system provides automated feedback by analyzing test results and comparing them against expected ranges. When results indicate incorrect anticoagulant usage, the system flags the error and alerts the user, creating a closed-loop feedback mechanism that corrects selection errors after they occur.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system performs self-verification by automatically detecting incorrect tube selection through algorithmic analysis of test results, eliminating the need for manual verification by the user. The analyzer independently identifies and reports errors without requiring additional user attention.

Inventive Principle:
Principle #25Self-service

2Reliability

If reportable ranges are used to flag abnormal results, then some errors can be detected, but the system cannot distinguish between sensor malfunctions and incorrect sample collection

Engineering Contradiction:
Improveerror detection capabilityVSAvoiderror cause identification
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The system segments the error detection process by analyzing multiple individual test results separately and comparing each against expected physiological ranges. This granular analysis allows the system to identify patterns specific to incorrect anticoagulant usage rather than treating all abnormal results as a single category.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system changes the detection parameter from simple reportable range flagging to multi-parameter algorithmic analysis. By evaluating multiple analytes simultaneously and comparing their interrelationships against expected physiological correlations, the system can distinguish between sensor malfunctions and collection errors.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If multiple anticoagulant types are available for different tests, then test versatility is improved, but the complexity of selecting the correct tube increases

Engineering Contradiction:
Improvetest compatibilityVSAvoidcollection tube selection
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system provides a universal solution that works across all anticoagulant types and test configurations. The algorithm automatically adapts to different tube types by analyzing the specific pattern of affected analytes, eliminating the need for users to memorize which tube to use for each test.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system introduces an intermediary layer (the algorithmic analysis system) between the diverse tube types and the user. This intermediary automatically interprets the complex relationships between different anticoagulants and test requirements, presenting a simplified interface to the user.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Reliability

If prior art systems flag out-of-range results, then abnormal values are identified, but no explicit alert is provided that the wrong collection device was used

Engineering Contradiction:
Improveabnormal result identificationVSAvoidcollection error notification
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The system provides explicit feedback by not only flagging abnormal results but also communicating the specific cause (incorrect collection device) to the user through clear alerts and recommendations for corrective action.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system introduces an intermediary communication layer that translates complex analytical findings into user-friendly alerts. The intermediary converts algorithmic error detection into actionable information that clearly guides the user on what went wrong and how to fix it.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Effectively prevents and detects erroneous sample collections by flagging affected results and alerting users to the correct anticoagulant usage, ensuring clinically valid results and improving the reliability of point-of-care testing.

Implementation Method 1

using sensors like ion-selective electrodes to determine divalent and monovalent cations and other analytes

Methodology Applied
Scientific EffectIon-selective detection:

Data Source

PatentUS8548772B2Automated method and apparatus for detecting erroneous sample collection in clinical assays
Publication Date: 2013.10.01 ABBOTT POINT OF CARE INC
  • US8548772B2 patent drawing
  • US8548772B2 patent drawing
  • US8548772B2 patent drawing

AI summary

An automatic method for identifying biological samples that are collected using the wrong blood preservative for subsequent analytical testing. The method also provides for identification and/or suppression of certain analytical test results that are substantially or partly adversely affected. The invention is particularly suited for use in point-of-care medical diagnostic testing.